SREBF1 and metabolic dysfunction-associated steatotic liver disease: According to the reports that activation of SREBP-1c promoted hepatic lipogenesis and aggravated NAFLD symptoms [38], recently, several reports revealed that regulating PPARα and SREBP-1c could ameliorate NAFLD.